(Q35978501)

11 August 2017

Metabolism of ifosfamide during a 3 day infusion (English)

1 reference

11 August 2017

1 reference

Hartley JM

1

1 reference

11 August 2017

Hansen L

2

1 reference

11 August 2017

Harland SJ

3

1 reference

11 August 2017

Nicholson PW

4

1 reference

11 August 2017

Pasini F

5

1 reference

11 August 2017

Souhami RL

6

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 May 1994

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

69

1 reference

11 August 2017

931-936

1 reference

11 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1994.180

11 August 2017

0 references

cites work

Ifosfamide, mesna, and nephrotoxicity in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968912

Metabolism of oxazaphosphorines

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968912

Fractionated ifosfamide therapy produces a time-dependent increase in ifosfamide metabolism

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968912

Magnetic resonance spectroscopy: a powerful tool for drug metabolism studies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968912

Prediction of creatinine clearance from serum creatinine

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968912

Pharmacokinetics and bioavailability of oral ifosfamide

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968912

Pharmacokinetics of divided‐dose ifosfamide

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968912

Isophosphamide as a new acrolein-producing antineoplastic isomer of cyclophosphamide

11 July 2018

1 reference

12 December 2020

Pharmacokinetics and metabolism of ifosfamide administered as a continuous infusion in children

1 reference

12 December 2020

Studies on the metabolism of isopnosphamide (NSC-109724) in man

1 reference

12 December 2020

Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention. 2. Comparative study on the uroprotective efficacy of thiols and other sulfur compounds

1 reference

12 December 2020

Pharmacokinetic studies in lung cancer patients

1 reference

12 December 2020

Dechloroethylation of ifosfamide and neurotoxicity

1 reference

12 December 2020

Phenotypically deficient urinary elimination of carboxyphosphamide after cyclophosphamide administration to cancer patients

1 reference

12 December 2020

Comparative pharmacokinetics and alkylating activity of fractionated intravenous and oral ifosfamide in patients with bronchogenic carcinoma

1 reference

12 December 2020

The effect of route of administration and fractionation of dose on the metabolism of ifosfamide

1 reference

12 December 2020

Combined thin-layer chromatography-photography-densitometry for the quantification of ifosfamide and its principal metabolites in urine, cerebrospinal fluid and plasma

1 reference

12 December 2020

Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1994.180

1 reference

Dimensions Publication ID

11 August 2017

1007409960

0 references

Fatcat ID

release_u5d2kq2yunf2nghp5vq7odb47a

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/u5d2kq2yunf2nghp5vq7odb47a

24 November 2022

mapped directly with Wikidata item

1 reference

11 August 2017

1 reference